The cAMP Hunter Semaglutide Bioassay Kit provides an easy-to-use cell based assay to measure drug potency and detect neutralizing antibodies. This bioassay asseses ligand (e.g. Exendin-4) based on activation of GLP1R GPCR activity via detection of cAMP. The included cell line overexpresses ProLink-tagged GLP1R and EA-tagged . Activation of GLP1R stimulates the recruitment of and produces EFC signal.This assay has been optimized and qualified with Semaglutide (not supplied in the bioassay kit). Ozempic® is a registered trademark of Novo Nordisk A/S. Bioassay kits are a convenient, ready-to-use format which contains all materials needed to run the assay, including single-use vials of cryopreserved cells, cell plating media, control agonist, detection reagent, and assay plates.